Tag Michael J. Singh

Since the US Food and Drug Administration (FDA) approved the first thoracic endovascular aortic endograft repair (TEVAR) in 2005, its use has rapidly increased. , In a relatively short period of time, TEVAR for descending thoracic aortic aneurysms (DTAA) and…

Thoracic aortic pathology is one of the leading causes of death in the world in those over the age of 65 and in the United States accounts for more than 11,000 deaths annually. Thoracic aortic aneurysms (TAAs) occur less frequently…